NASDAQ
Mayne Pharma Group Limited (MAYNF) has a free cash flow growth of -137.34% as of Friday, May 29, 2026. This represents a 30.45% decrease compared to its 12-month average of -105.28%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.